Inimmune Corporation
Latest round
- Series A
Last raised
- Jul 2020
Total raised
- $22M
Investors
- 1
About Inimmune Corporation
Founded in 2016 and based in Montana, US, Inimmune Corporation is a biotechnology company that focuses on developing vaccines and immunotherapeutics in the areas of oncology, allergic rhinitis, food allergy, and infectious disease vaccines, as well as novel antibiotics for bacterial infections.
Who invested in Inimmune Corporation
1 investor across 1 round
See all investors in Inimmune Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 9, 2020
Amount
$22M
Investors
Questions about Inimmune Corporation
Who invested in Inimmune Corporation?
Inimmune Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inimmune Corporation raised?
Inimmune Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inimmune Corporation last raise money?
Inimmune Corporation's most recent round on record is a Series A, in Jul 2020.
What does Inimmune Corporation do?
Founded in 2016 and based in Montana, US, Inimmune Corporation is a biotechnology company that focuses on developing vaccines and immunotherapeutics in the areas of oncology, allergic rhinitis, food allergy, and infectious disease vaccines, as well as novel antibiotics for bacterial infections.
Where is Inimmune Corporation headquartered?
Inimmune Corporation is headquartered in Missoula, US.
Which VCs invest in companies like Inimmune Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Inimmune Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Inimmune Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.